ROLE OF PRE-CESAREAN SECTION CEFOTAXIME IN AMELIORATED POST-CESAREAN COMPLICATION

Wiad Lek. 2022;75(4 pt 1):818-823. doi: 10.36740/WLek202204113.

Abstract

Objective: The aim: The purpose of this study was to examine the efficacy of cefotaxime before and after skin incision in avoiding post-operative infection complications in caesarean section women, also evaluation the efficacy of cefotaxime in reducing post-caesarean section complications.

Patients and methods: Materials and methods: We conducted 150 women who undergoing caesarean section in the Obstetrics & Gynecological Department, Babylon government from January, 2021 to March, 2021. The caesarean operations were done by using standard protocols. Each patient was examined daily and post-operative infectious. Women were randomly divided into three groups; each group contains 50 women; Group 1: (control) given normal saline 12 hr. before and after skin incision. Group 2 (pre-operation antibiotic): given single dose of cefotaxime 1 g intravenously 12 hr. before skin incision, and Group 3 (post-operation antibiotic): given single dose of cefotaxime 1 g intravenously 12 hr after operation.

Results: Results: The outcome measures were post-operative febrile morbidity, healing period and urinary tract infections, in addition to socioeconomic state of each woman.

Conclusion: Conclusions: cefotaxime pre-cesarean section could ameliorate post-operative problems such as infection of surgical wound, febrile, and urinary tract infections.

Keywords: and post-operative febrile; cefotaxime; cesarean section; surgical site infection; wound infection.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cefotaxime / therapeutic use
  • Cesarean Section* / adverse effects
  • Cesarean Section* / methods
  • Female
  • Humans
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control
  • Pregnancy
  • Surgical Wound Infection / drug therapy
  • Surgical Wound Infection / etiology
  • Surgical Wound Infection / prevention & control
  • Urinary Tract Infections* / drug therapy
  • Urinary Tract Infections* / etiology
  • Urinary Tract Infections* / prevention & control

Substances

  • Anti-Bacterial Agents
  • Cefotaxime